PGIMS recalls drug amid probe into deaths
NPPA list brings little relief: No price cut for 25% cancer drugs
Centre Mandates Minimum One-Year Shelf Life For Imported Drugs
For Aakash Healthcare, Community People are Apples of its Eyes
Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA
Yashoda Medicity: Baby takes a Giant Step in just One Year
Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore
GLP-1 injections recalled across the US over sterility concerns
Govt allows third-party agencies to conduct departmental inspections
Fridge-free vaccines could reach more people, but there are still practical challenges in African settings
Illegally stocked drugs worth Rs 5.21 lakh seized
HYDERABAD: The Drugs Control Administration (DCA) raided the residence of a habitual offender in Moosarambagh, Malakpet, and seized spurious drugs worth Rs 5.21 lakh. The accused, Puvvada Lakshmana, is a…
Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions
AIIMS Bhopal has taken a historic step toward integrating Indian systems of medicine with modern healthcare through a Memorandum of Understanding (MoU) signed with the Patanjali Research Foundation Trust. This…
NPPA fixes retail prices for 41 drug combinations, including empagliflozin
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 41 drug combinations, including 18 variants of the off-patent diabetes drug empagliflozin, originally developed by German pharmaceutical company…
Drug Inspector Dismissed After Rs 4 Crore Cash Found in Sacks; Linked to Illegal Sale of Pharmacist Degrees
Patna: A drug inspector in Bihar has been dismissed from service following the discovery of Rs 4 crore in cash during a raid in 2022, along with evidence of extensive corruption,…
Delhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals
New Delhi : The Crime Branch of Delhi Police has busted a racket selling spurious cancer medicines and injections, arresting six individuals and seizing several high-value spurious cancer drugs on…
‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New York
New Delhi: It was a hallowed moment of pride for surgical robot SSI Mantra, its architect and robotic surgery wizard Dr Sudheer Srivastava, entire Indian Medtech Industry and ‘Make in…
Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million
Zydus Lifesciences plans to acquire Nasdaq-listed clinical-stage immuno-oncology firm Agenus’s two biologics manufacturing facilities in California, U.S. for $125 million to enter the global biologics contract development and manufacturing organization…
Ananda Pharma advances CBD drug with Phase 1 study listing
LONDON – Ananda Pharma PLC (AQSE:ANA), a UK-based biopharmaceutical company, has announced the publication of its Phase 1 pharmacokinetic study on the clinical trial registry clinicaltrials.gov, with the reference number…
With Advent of Level Playing Field, Domestic MedTech Industry exclaims ‘Eureka!’
AiMed showers unqualified praise on Government for jettisoning foreign favoritism New Delhi: Rajiv Nath, one of the greatest champions of Make in India and no nonsense leader of domestic medical…
Govt supports indigenous manufacturing of complex pharma excipients by Nitika Pharmaceutical Specialties
For commercial-scale production of 14 complex excipients The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties Private…
